Stock MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Medical Developments International Limited

Equities

MVP

AU000000MVP2

Market Closed - Australian S.E.
Other stock markets
 07:10:44 26/04/2024 BST 		5-day change 1st Jan Change
0.54 AUD -3.57% Intraday chart for Medical Developments International Limited -4.42% -28.95%
02-29 Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024
02-28 Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Medical Developments International Limited Announces Resignation of David Williams from Board
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%
Medical Developments International Limited Discontinues China Clinical Trials
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited
Medical Developments International Limited Announces Board Changes
Australian Shares Post Modest Gains as GDP Rebounds in Q4 2021
Medical Developments Secures US FDA Approval for Phase 3 Pain Medication Trial; Shares Surge 30%
Medical Developments International Limited Announces That US Food and Drug Administration Lifts Clinical Hold on Penthrox
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MVP Stock
  4. News Medical Developments International Limited
  5. Other languages